DHG Pharmaceutical JSC (HOSE: DHG)
Vietnam
· Delayed Price · Currency is VND 101,500
-1,800 (-1.74%)
At close: Jan 21, 2025
DHG Pharmaceutical JSC Income Statement
Financials in millions VND. Fiscal year is January - December.
Millions VND. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Revenue | 4,884,868 | 4,884,868 | 5,015,395 | 4,676,016 | 4,003,170 | 3,755,619 | Upgrade
|
| Revenue Growth (YoY) | -2.60% | -2.60% | 7.26% | 16.81% | 6.59% | -3.62% | Upgrade
|
| Cost of Revenue | 2,747,102 | 2,747,102 | 2,671,850 | 2,418,521 | 2,082,260 | 1,944,243 | Upgrade
|
| Gross Profit | 2,137,766 | 2,137,766 | 2,343,545 | 2,257,495 | 1,920,911 | 1,811,376 | Upgrade
|
| Selling, General & Admin | 1,217,491 | 1,217,491 | 1,291,264 | 1,181,417 | 1,060,127 | 1,002,160 | Upgrade
|
| Operating Expenses | 1,217,491 | 1,217,491 | 1,291,264 | 1,181,417 | 1,060,127 | 1,002,160 | Upgrade
|
| Operating Income | 920,276 | 920,276 | 1,052,281 | 1,076,078 | 860,784 | 809,216 | Upgrade
|
| Interest Expense | -24,811 | -24,811 | -29,530 | -12,559 | -12,080 | -14,030 | Upgrade
|
| Interest & Investment Income | - | - | 202,173 | 120,337 | 114,306 | 133,858 | Upgrade
|
| Earnings From Equity Investments | - | - | - | - | - | -500.64 | Upgrade
|
| Currency Exchange Gain (Loss) | - | - | 5,580 | 3,587 | 4,160 | -2,966 | Upgrade
|
| Other Non Operating Income (Expenses) | 9,019 | 9,019 | -73,082 | -89,517 | -93,955 | -84,764 | Upgrade
|
| EBT Excluding Unusual Items | 904,485 | 904,485 | 1,157,423 | 1,097,926 | 873,214 | 840,814 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | 315 | -772.55 | 274.7 | -14,605 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | 1,437 | 2,518 | -7,999 | 3,264 | Upgrade
|
| Asset Writedown | - | - | - | - | - | -3,011 | Upgrade
|
| Other Unusual Items | - | - | - | -58.33 | -1,488 | -5,438 | Upgrade
|
| Pretax Income | 904,485 | 904,485 | 1,159,174 | 1,099,613 | 864,002 | 821,024 | Upgrade
|
| Income Tax Expense | 125,564 | 125,564 | 108,512 | 111,159 | 87,717 | 82,490 | Upgrade
|
| Earnings From Continuing Operations | 778,920 | 778,920 | 1,050,663 | 988,455 | 776,285 | 738,534 | Upgrade
|
| Minority Interest in Earnings | - | - | - | - | 934.93 | 1,341 | Upgrade
|
| Net Income | 778,920 | 778,920 | 1,050,663 | 988,455 | 777,220 | 739,875 | Upgrade
|
| Preferred Dividends & Other Adjustments | 25,368 | 25,368 | 33,520 | 31,654 | 29,317 | 28,196 | Upgrade
|
| Net Income to Common | 753,553 | 753,553 | 1,017,143 | 956,801 | 747,903 | 711,679 | Upgrade
|
| Net Income Growth | -25.86% | -25.86% | 6.29% | 27.18% | 5.05% | 16.44% | Upgrade
|
| Shares Outstanding (Basic) | 131 | 131 | 131 | 131 | 131 | 131 | Upgrade
|
| Shares Outstanding (Diluted) | 131 | 131 | 131 | 131 | 131 | 131 | Upgrade
|
| EPS (Basic) | 5763.48 | 5763.48 | 7779.53 | 7318.01 | 5720.27 | 5443.21 | Upgrade
|
| EPS (Diluted) | 5763.48 | 5763.48 | 7779.53 | 7318.01 | 5720.27 | 5443.21 | Upgrade
|
| EPS Growth | -25.91% | -25.91% | 6.31% | 27.93% | 5.09% | 16.61% | Upgrade
|
| Free Cash Flow | 1,228,879 | 1,228,879 | -246,171 | 667,293 | 427,882 | 737,369 | Upgrade
|
| Free Cash Flow Per Share | 9398.97 | 9398.97 | -1882.82 | 5103.73 | 3272.62 | 5639.70 | Upgrade
|
| Dividend Per Share | - | - | 7500.000 | 3500.000 | 3500.000 | 4000.000 | Upgrade
|
| Dividend Growth | - | - | 114.29% | 0% | -12.50% | 0% | Upgrade
|
| Gross Margin | 43.76% | 43.76% | 46.73% | 48.28% | 47.98% | 48.23% | Upgrade
|
| Operating Margin | 18.84% | 18.84% | 20.98% | 23.01% | 21.50% | 21.55% | Upgrade
|
| Profit Margin | 15.43% | 15.43% | 20.28% | 20.46% | 18.68% | 18.95% | Upgrade
|
| Free Cash Flow Margin | 25.16% | 25.16% | -4.91% | 14.27% | 10.69% | 19.63% | Upgrade
|
| EBITDA | 1,089,971 | 1,089,971 | 1,140,001 | 1,157,079 | 943,348 | 897,413 | Upgrade
|
| EBITDA Margin | 22.31% | 22.31% | 22.73% | 24.74% | 23.57% | 23.90% | Upgrade
|
| D&A For EBITDA | 169,695 | 169,695 | 87,720 | 81,001 | 82,564 | 88,197 | Upgrade
|
| EBIT | 920,276 | 920,276 | 1,052,281 | 1,076,078 | 860,784 | 809,216 | Upgrade
|
| EBIT Margin | 18.84% | 18.84% | 20.98% | 23.01% | 21.50% | 21.55% | Upgrade
|
| Effective Tax Rate | 13.88% | 13.88% | 9.36% | 10.11% | 10.15% | 10.05% | Upgrade
|
| Revenue as Reported | 4,884,868 | 4,884,868 | 5,015,395 | 4,676,016 | 4,003,170 | 3,755,619 | Upgrade
|
| Advertising Expenses | - | - | 128,162 | 138,011 | 138,095 | 119,136 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.